University can claim sovereign immunity in cancer treatment suit, rules Federal Circuit

28-07-2020

Muireann Bolger

University can claim sovereign immunity in cancer treatment suit, rules Federal Circuit

wildpixel / iStockphoto.com

The dispute arises from the biotechnology company Gensetix’s acquisition of exclusive licencing of US patent numbers 8,728,806 and 9,333,248 from the University of Texas in 2014.


Gensetix, Baylor College of Medicine, University of Texas, patents, lawsuit

LSIPR